AI for Pharma and Biotech Market
Request Sample Report
AI for Pharma and Biotech Market Size and Growth
The AI for Pharma and Biotech market is experiencing substantial growth, driven by advancements in drug discovery, clinical trials, and personalized medicine. As of 2023, the market is valued at approximately $3 billion, with expectations to exceed $10 billion by 2030, reflecting increasing investments and technological integration in the sector.
Companies Covered
(Covid 19 Impact Covered)
◍ CureMetrix
◍ Enlitic
◍ VoxelCloud
◍ Insilico Medicine
◍ Oncora Medical
◍ Atomwise
◍ TwoXAR
◍ Berg Health
◍ CloudMedX
◍ Deep Genomics
◍ Johnson & Johnson
◍ Roche
◍ Pfizer
◍ Novartis
◍ Bayer
The AI for Pharma and Biotech market features companies like CureMetrix, Enlitic, and Atomwise that enhance drug discovery and diagnostics. Johnson & Johnson, Roche, and Pfizer leverage AI for R&D. These firms boost market growth through innovative solutions. Revenue figures include:
- Pfizer: $81.3 billion
- Roche: $64.2 billion
- Novartis: $50.5 billion.
Request Sample Report
Market Segmentation
By Application
Hospital
Clinic
Research Center
Others
Request Sample Report
By Product
Deep Learning
Big Data
Image Detection
Others
Market Growth
Request Sample Report
$ X Billion USD
